Skip to main content
. Author manuscript; available in PMC: 2021 Aug 6.
Published in final edited form as: Catheter Cardiovasc Interv. 2020 May 30;97(6):1129–1138. doi: 10.1002/ccd.29003

Table 2:

Inpatient mortality, cost and LOS in Bleeding complications

Total Bleeding complications
In-Hospital mortality Length of Stay (in days)** Cost of Hospitalization (in dollars)
With bleeding complications No./Total (%) Without bleeding complications No./Total (%) p-value Adjusted Odds Ratio* p-Value With bleeding complications Without bleeding complications p-value With bleeding complications Without bleeding complications p-value
Cardiogenic shock with STEMI 8616/31388 (27.4%) 43432/14110 2 (30.8%) <0.001 0.79 (0.77–0.81) <0.001 15 10 <0.001 210,258 139,409 <0.001
CS with STEMI without MCS 3810/12869 (29.4%) 23652/68151 (34.7%) <0.001 0.72 (0.69–0.75) <0.001 14 8 <0.001 166,063 95,576 <0.001
CS with STEMI and IABP 4106/16877 (24.3%) 18268/69918 (26.1%) <0.001 0.82 (0.79–0.86) <0.001 14 11 <0.001 155,176 220,107 <0.001
CS with STEMI and PVAD 201/603 (32.3%) 653/1457 (44.8%) <0.001 0.66 (0.52–0.83) <0.001 18 13. <0.001 403,242 265,020 <0.001
CS with STEMI and ECMO 122/241 (50.6%) 126/203 (62.1%) 0.01 0.67 (0.37–1.22) 0.19 27 24 0.23 523,168 437,824 0.36
*

Adjusted for age, sex, race, smoking status, dyslipidemia, alcohol abuse, congestive heart failure, liver disease, peripheral vascular disease, deficiency anemia, chronic pulmonary disease, coagulopathy, renal failure diabetes, hypertension, cardiac arrest and vasopressor use.

**

included all patients that survived the index admission.